Diagnostics and longitudinal monitoring - interpreted in context.
Medical Evidence AI connects tumour biology, molecular biomarkers, pathology, imaging, immune status, circulating tumour cells and longitudinal findings instead of treating each result as an isolated value.
From a laboratory value to a clinically useful evidence question
The platform separates findings that can directly influence established treatment selection from supportive or exploratory measurements. Reference ranges, assay method, date and treatment context remain visible so that trends are not mistaken for causal effects.
Immune status
T cells, CD4/CD8, B cells, NK/NKT cells and monocytes - absolute and relative values, laboratory reference ranges and longitudinal context.
Open detailed topic →Tumour count / CTC
Circulating tumour cells and rare-cell findings with assay method, marker, measurement date and methodological limitations.
Open detailed topic →Tumour dynamics
Multiple time points can be compared with treatment, imaging and clinical course rather than interpreted as a single snapshot.
Open detailed topic →Liquid biopsy
ctDNA, CTC and circulating markers: what they may contribute and where tissue pathology or imaging remains essential.
Open detailed topic →Genetics & molecular biomarkers
Somatic and germline alterations, actionable targets, resistance markers and gaps in molecular testing.
Open detailed topic →Pathology
Histology, grading, receptor status and integrated molecular pathology as the basis for evidence matching.
Open detailed topic →Imaging
CT, MRI, PET and response assessment are placed on the same timeline as treatment and laboratory findings.
Open detailed topic →Biomarkers
Predictive, prognostic and monitoring biomarkers are explicitly distinguished to reduce over-interpretation.
Open detailed topic →What can be entered into a case?
Diagnosis and stage → pathology → molecular biomarkers → imaging → previous and current treatments → standard laboratory results → immune profile → CTC/tumour dynamics → clinical course.
The result is a structured evidence synthesis for professional review, not an autonomous diagnosis or treatment decision.
Start 3 free pilot analyses